Evista - Another Osteoporosis Drug: How Safe Is It?
September 1, 2006 16:49

Evista, a drug used to treat the bone disease osteoporosis is seeking approval to be marketed for breast cancer prevention. Women with heart disease or a high risk for it would trade one set of odds for another if they took the drug raloxifene (Evista) to try to prevent breast cancer Evista, may help prevent cancer, but raises the risk of blood clots and fatal strokes. Breast cancer is more treatable than life threatening heart attacks and strokes. (MSNBC)

American Dental Association and Oral Bisphosphonates
September 2, 2006 16:48

Relying on a small but growing number of reports linking bisphosphonate drugs like Fosamax, Boniva, and Actonel to incidences of osteonecrosis of the jaw (dead bone tissue), a panel of American Dental Association experts believe that dentists should discuss ONJ risks with dental patients who are taking Fosamax, Boniva, and Actonel when performing tooth extraction or doing implants. Dentists and their patients should carefully consider these procedures and discuss alternative dental therapies. (Osseo News)